Publications
5674 Results
- Journal / Conference
- Journal of the National Cancer Institute 94(4):291-297
- Year
- 2002
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9509
Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small cell lung cancer
- Journal / Conference
- Quality of Life Research 11:115-126
- Year
- 2002
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9509
Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial
- Journal / Conference
- Investigational New Drugs 20:105-111
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9505
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy - Southwest Oncology Group study
- Journal / Conference
- Investigational New Drugs 20:113-115
- Year
- 2002
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-8829
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study
- Journal / Conference
- Investigational New Drugs 20:117-121
- Year
- 2002
- Research Committee(s)
- Myeloma
- Study Number(s)
- S9803
The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study
- Journal / Conference
- Blood 99(9):3163-3168
- Year
- 2002
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9210
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients
- Journal / Conference
- Journal of Clinical Oncology 20(16):3454-3460
- Year
- 2002
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9019
Concurrent cisplatin, etoposide and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer: a Southwest Oncology Group Phase II study (SWOG-9019
- Journal / Conference
- Gynecologic Oncology 87:17-23
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9521
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy, and its prognostic role: a Southwest Oncology Group ancillary study
- Journal / Conference
- Journal of Clinical Oncology 20(8):2067-2075
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9035
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome.
- Journal / Conference
- Journal of Clinical Oncology 20(6):1499-1505
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8990 (INT-0103) (EST-9288)